An insight of different classes of RNA-based therapeutic, nanodelivery and clinical status: Current landscape
The first RNA therapeutic molecule, Fomivirsen, was approved for a clinic in 1998 as an antisense oligonucleotide therapeutic. Twenty-four years later, we found that more than a dozen RNA therapeutics had received approval and entered the clinic. In this direction, the review article illustrated the...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2023-01-01
|
| Series: | Current Research in Biotechnology |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2590262823000321 |